COMMUNIQUÉS West-GlobeNewswire

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

19/07/2024 - 18:00

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital [...]

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux

19/07/2024 - 17:30

Daix (France), Long Island City (New York, United States), July 19, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (“ Inventiva ” or the “ Company ”), a clinical-stage biopharmaceutical company focused on the [...]

Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux

19/07/2024 - 17:30

Daix (France), Long Island City (New York, Etats-Unis), le 19 juillet 2024 – Inventiva (Euronext Paris et Nasdaq: IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement [...]

Capra Biosciences Lands $7.5 Million Project Agreement To Demonstrate Platform To Rapidly Scale Pharmaceutical Ingredient Manufacturing

19/07/2024 - 16:00

BioMaP-Consortium Project Agreement Will Combine Sustainable Biochemical Production with AI To Demonstrate a Scalable Platform for the Quick Manufacture of Pharmaceutical Ingredients STERLING, Va., July 19, 2024 (GLOBE [...]

Rakovina Therapeutics Announces Second Upsizing of Private Placement

19/07/2024 - 15:47

All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, July 19, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (the “Company”), a biopharmaceutical [...]

Altamira Therapeutics Announces Publication of Preclinical Data Showing Successful Treatment of Abdominal Aortic Aneurysm with SOD2 mRNA Delivered by SemaPhore Nanoparticles

19/07/2024 - 15:01

Hamilton, Bermuda, July 19, 2024 (GLOBE NEWSWIRE) -- Study shows significant reduction in aorta dilation, delayed rupture and lower mortality in established animal model of abdominal aortic aneurysm Altamira’s SemaPhore [...]

Shuttle Pharma’s Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONE

19/07/2024 - 15:00

GAITHERSBURG, Md., July 19, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving [...]

Announces Pricing of $5.0 Million Registered Direct Offering and Concurrent Private Placement

19/07/2024 - 14:30

July 19, 2024 Biodexa Pharmaceuticals PLC Announces Pricing of $5.0 Million Registered Direct Offering and Concurrent Private Placement Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), an [...]

Palisade Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent for Lead Product Candidate, PALI-2108

19/07/2024 - 14:30

Patent includes Composition of Matter claims for both PALI-2108 and PALI-1908 programs Patent includes broad claims for “Gut Microbiota Bioactivated PDE4 Inhibitor Precursors” with similar structure to PALI-2108 and [...]

60 Degrees Pharmaceuticals Signs Clinical Trial Agreements With All Planned Trial Sites for Tafenoquine Babesiosis Study

19/07/2024 - 14:29

The Tafenoquine for Babesiosis clinical trial will be conducted at three sites: Yale University, Rhode Island Hospital and Tufts Medical Center Patient enrollment has begun; interim results anticipated by September, [...]

Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

19/07/2024 - 14:01

SARASOTA, FL, July 19, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery [...]

Daré Bioscience Regains Compliance with Nasdaq Minimum Bid Price Rule

19/07/2024 - 14:00

SAN DIEGO, July 19, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing of women, announced that it was notified by the Nasdaq Office of General Counsel [...]

Inspire Medical Systems, Inc. Announces CE Mark Certification of Full-Body MRI Compatibility under the European Union’s Medical Device Regulation

19/07/2024 - 14:00

MINNEAPOLIS, July 19, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive [...]

Inspire Medical Systems, Inc. annonce l’approbation du marquage CE qui atteste de la compatibilité de ses appareils avec les examens IRM corps entier et de leur conformité aux exigences du règlement de l’Union européenne sur les dispositifs médicaux

19/07/2024 - 14:00

MINNEAPOLIS, 19 juill. 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE : INSP) (Inspire), entreprise de technologies médicales qui s’attache au développement et à la commercialisation de solutions [...]

Inspire Medical Systems, Inc. Announces CE Mark Certification under the European Union’s Medical Device Regulation for Inspire Therapy

19/07/2024 - 14:00

MINNEAPOLIS, July 19, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive [...]

Inspire Medical Systems, Inc. annonce l’approbation du marquage CE qui atteste de la conformité de la thérapie Inspire aux exigences du règlement de l’Union européenne sur les dispositifs médicaux

19/07/2024 - 14:00

MINNEAPOLIS, 19 juill. 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE : INSP) (Inspire), entreprise de technologies médicales qui s’attache au développement et à la commercialisation de solutions [...]

SIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX®

19/07/2024 - 14:00

Exercise of Procurement Option under Current Contract Reflects Continuing Action to Enhance Orthopoxvirus Preparedness NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a [...]

Clearmind Medicine Signs an Agreement to Source Manufacturers and Distributors for its Alcohol Substitute Beverage Product

19/07/2024 - 13:55

Vancouver, Canada, July 19, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]

SweetWater Brewing Launches New Rowdy Peach IPA in Collaboration With Atlanta United FC

19/07/2024 - 13:00

As Atlanta United’s Official Craft Beer Partner, SweetWater’s New Brew Celebrates the Rowdiest Fans in MLS ATLANTA, July 19, 2024 (GLOBE NEWSWIRE) -- Calling all 17s 1 ! SweetWater Brewing Company (“SweetWater Brewing” [...]